论文部分内容阅读
目的观察双歧杆菌三联活菌散(培菲康)联合四联疗法根除幽门螺杆菌(Hp)感染的效果。方法 80例Hp感染者,随机分为观察组和对照组,各40例。对照组采用四联疗法,观察组在对照组基础上加用培菲康。两组均治疗10 d,治疗结束4周后,采用13碳尿素呼气试验检测Hp阳性率。结果观察组Hp阳性率为10.0%,对照组为37.5%,比较差异有统计学意义(P<0.05);观察组总阳性率(62.5%)显著高于对照组(40.0%)(P<0.05);观察组出现味觉异常3例,腹泻3例,粪便黑色3例,对照组分别为8、5、4例,其中对照组还有2例出现便秘。两组不良反应情况比较差异有统计学意义(P<0.05)。结论培菲康联合四联疗法可明显提高Hp根除率,值得临床推广应用。
Objective To observe the efficacy of Bifidobacterium triple inactivated bacilli combined with quadruple therapy in the eradication of Helicobacter pylori (Hp) infection. Methods 80 cases of Hp infection were randomly divided into observation group and control group, 40 cases each. Control group with quadruple therapy, the observation group in the control group based on the use of Peifei Kang. Two groups were treated for 10 days, after the end of treatment for 4 weeks, 13 carbon urea breath test was used to detect the positive rate of Hp. Results The positive rate of Hp in observation group was 10.0%, while that in control group was 37.5% (P <0.05). The positive rate of observation group was significantly higher than that of control group (62.0%) (P <0.05) ). In the observation group, there were 3 cases of taste abnormality, 3 cases of diarrhea and 3 cases of stool black. The control group were 8, 5 and 4 cases respectively. In the control group, 2 cases showed constipation. Adverse reactions between the two groups were statistically significant (P <0.05). Conclusion Pefloxacin combined with quadruple therapy can significantly improve the Hp eradication rate, worthy of clinical application.